Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Paxmedica Inc
(NQ:
PXMD
)
0.6883
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Paxmedica Inc
< Previous
1
2
3
4
Next >
New Study Challenges Perception of Males Being More Susceptible to Autism
February 02, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Dedicated to Enhancing Quality of Life for Individuals Living with ASD
January 26, 2024
Via
Investor Brand Network
Study Suggests Pediatric Autism Could Be Linked to Umbilical Cord Lipid Levels at Birth
January 19, 2024
Via
Investor Brand Network
InvestorBrandNetwork Highlights PaxMedica Inc.’s (NASDAQ: PXMD) Video Release on Transformative ASD Study
January 16, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) on Promising Path to Address Unmet ASD Needs
January 12, 2024
Via
Investor Brand Network
PaxMedica Releases Fireside Chat Video with CEO Howard Weisman
December 06, 2023
Via
ACCESSWIRE
Israeli Study Offers Hope to Sleeping Sickness Patients
December 26, 2023
Via
Investor Brand Network
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Files 8-K Following Nasdaq Compliance Achievement
December 21, 2023
Via
Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Fireside Chat with CEO Howard Weisman Sheds Light on Company Achievements for ASD Therapy Pipeline
December 18, 2023
Via
Investor Brand Network
Chinese Researchers Notch Major Milestone in Developing Gene Editing System Against Autism
December 13, 2023
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) CEO Featured in Just-Released Fireside Chat Video
December 06, 2023
Via
Investor Brand Network
Exposures
Product Safety
PaxMedica Inc. (NASDAQ: PXMD) Completes Key Type-B FDA Meeting, Discussing Positive Results from PAX-HAT-301 Study
December 06, 2023
Via
Investor Brand Network
Exposures
Product Safety
PaxMedica Inc. (NASDAQ: PXMD) Closes Public Offering of Approximately $7 Million and Continues Pursuing ASD Pipeline
December 05, 2023
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Featured in Recent H.C. Wainwright & Co. Research Report with ‘Buy’ Rating, $3 PT
December 04, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Study Shows Autistic People Have Lower Life Expectancy Than General Population
December 01, 2023
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Closes on Public Offering Reaching Estimated $7M
November 27, 2023
Via
Investor Brand Network
PaxMedica Announces Closing of $7.0 Million Public Offering
November 22, 2023
Via
ACCESSWIRE
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Announces Pricing of $7M Public Offering
November 20, 2023
Via
Investor Brand Network
PaxMedica Announces Pricing of $7.0 Million Public Offering
November 20, 2023
Via
ACCESSWIRE
Study Examines Role of African Sleeping Sickness in Body Wasting
November 17, 2023
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) News of FDA Type-B Meeting Shared in Syndicated Audio Broadcast
November 17, 2023
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Releases Q3 2023 Financial Report, Corporate Update
November 16, 2023
Via
Investor Brand Network
Exposures
Product Safety
PaxMedica, Inc. Announces Third Quarter 2023 Financial Results and Business Update
November 15, 2023
Via
ACCESSWIRE
PaxMedica Inc. (NASDAQ: PXMD) Is Hoping to Boost Patient Independence with Potential ASD Treatment Amid Growing Prevalence Rates
November 14, 2023
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) CMO Featured in Latest Bell2Bell Podcast Release
November 09, 2023
Via
Investor Brand Network
Exposures
Product Safety
Study Finds Autism Compromises Sleep Quality, Physical Activity in Kids
November 07, 2023
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Phase 2 Study Results Published in Peer-Reviewed Journal
November 07, 2023
Via
Investor Brand Network
PaxMedica Announces Publication of Its Autism Spectrum Disorder Phase 2 Study Results in Peer-reviewed Journal
November 07, 2023
Via
ACCESSWIRE
PaxMedica Inc. (NASDAQ: PXMD) PRV Sale Prospects Strengthened by Recent Industry Developments
November 03, 2023
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD), Bourne Partners to Collaborate in Evaluating Future Monetization of Potential PRV
November 02, 2023
Via
Investor Brand Network
Exposures
Product Safety
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.